View Item 

Show simple item record

Coagulation factor VIIa binds to herpes simplex virus 1‐encoded glycoprotein C forming a factor X‐enhanced tenase complex oriented on membranes
dc.contributor.authorLin, Bryan H.
dc.contributor.authorSutherland, Michael R.
dc.contributor.authorRosell, Federico I.
dc.contributor.authorMorrissey, James H.
dc.contributor.authorPryzdial, Edward L. G.
dc.date.accessioned2020-07-02T20:33:25Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-07-02T20:33:25Z
dc.date.issued2020-06
dc.identifier.citationLin, Bryan H.; Sutherland, Michael R.; Rosell, Federico I.; Morrissey, James H.; Pryzdial, Edward L. G. (2020). "Coagulation factor VIIa binds to herpes simplex virus 1‐encoded glycoprotein C forming a factor X‐enhanced tenase complex oriented on membranes." Journal of Thrombosis and Haemostasis 18(6): 1370-1380.
dc.identifier.issn1538-7933
dc.identifier.issn1538-7836
dc.identifier.urihttps://hdl.handle.net/2027.42/155933
dc.description.abstractBackgroundThe cell membrane‐derived initiators of coagulation, tissue factor (TF) and anionic phospholipid (aPL), are constitutive on the herpes simplex virus type 1 (HSV1) surface, bypassing physiological regulation. TF and aPL accelerate proteolytic activation of factor (F) X to FXa by FVIIa to induce clot formation and cell signaling. Thus, infection in vivo is enhanced by virus surface TF. HSV1‐encoded glycoprotein C (gC) is implicated in this tenase activity by providing viral FX binding sites and increasing FVIIa function in solution.ObjectiveTo examine the biochemical influences of gC on FVIIa‐dependent FX activation.MethodsImmunogold electron microscopy (IEM), kinetic chromogenic assays and microscale thermophoresis were used to dissect tenase biochemistry. Recombinant TF and gC were solubilized (s) by substituting the transmembrane domain with poly‐histidine, which could be orientated on synthetic unilamellar vesicles containing Ni‐chelating lipid (Ni‐aPL). These constructs were compared to purified HSV1 TF±/gC ± variants.ResultsIEM confirmed that gC, TF, and aPL are simultaneously expressed on a single HSV1 particle where the contribution of gC to tenase activity required the availability of viral TF. Unlike viral tenase activity, the cofactor effects of sTF and sgC on FVIIa was additive when bound to Ni‐aPL. FVIIa was found to bind to sgC and this was enhanced by FX. Orientation of sgC on a lipid membrane was critical for FVIIa‐dependent FX activation.ConclusionsThe assembly of gC with FVIIa/FX parallels that of TF and may involve other constituents on the HSV1 envelope with implications in virus infection and pathology.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherherpesvirus
dc.subject.otherenzyme kinetics
dc.subject.othercoagulation factor
dc.subject.othertissue factor
dc.subject.otherenzyme mechanism
dc.titleCoagulation factor VIIa binds to herpes simplex virus 1‐encoded glycoprotein C forming a factor X‐enhanced tenase complex oriented on membranes
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155933/1/jth14790-sup-0001-Supinfo.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155933/2/jth14790.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155933/3/jth14790_am.pdf
dc.identifier.doi10.1111/jth.14790
dc.identifier.sourceJournal of Thrombosis and Haemostasis
dc.identifier.citedreferenceNuzzio KM, Watt ED, Boettcher JM, Gajsiewicz JM, Morrissey JH, Rienstra CM. High‐resolution NMR studies of human tissue factor. PLoS One. 2016; 11: e0163206.
dc.identifier.citedreferenceMackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009; 108: 1447 ‐ 1452.
dc.identifier.citedreferenceSutherland MR, Simon AY, Shanina I, Horwitz MS, Ruf W, Pryzdial ELG. Virus envelope tissue factor promotes infection in mice. J Thromb Haemost. 2019; 17: 482 ‐ 491.
dc.identifier.citedreferenceAltgärde N, Eriksson C, Peerboom N, et al. Mucin‐like region of herpes simplex virus type 1 attachment protein glycoprotein C (gC) modulates the virus‐glycosaminoglycan interaction. J Biol Chem. 2015; 290: 21473 ‐ 21485.
dc.identifier.citedreferenceMardberg K, Trybala E, Tufaro F, Bergstrom T. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate‐expressing gro2C cells. J Gen Virol. 2002; 83: 291 ‐ 300.
dc.identifier.citedreferenceRux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. Virology. 2002; 332: 324 ‐ 332.
dc.identifier.citedreferenceFriedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature. 1984; 309: 633 ‐ 635.
dc.identifier.citedreferenceHung SL, Peng C, Kostavasili I, et al. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology. 1994; 203: 299 ‐ 312.
dc.identifier.citedreferenceEtingin OR, Silverstein RL, Friedman HM, Hajjar DP. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell. 1990; 61: 657 ‐ 662.
dc.identifier.citedreferenceLivingston JR, Sutherland MR, Friedman HM, Pryzdial ELG. Herpes simplex virus type 1‐encoded glycoprotein C contributes to direct coagulation factor X‐virus binding. Biochem J. 2006; 393: 529 ‐ 535.
dc.identifier.citedreferenceSutherland MR, Friedman HM, Pryzdial ELG. Herpes simplex virus type 1‐encoded glycoprotein C enhances coagulation factor VIIa activity on the virus. Thromb Haemost. 2004; 92: 947 ‐ 955.
dc.identifier.citedreferenceTal‐Singer R, Peng C, Ponce De Leon M, et al. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol. 1995; 69: 4471 ‐ 4483.
dc.identifier.citedreferenceWillis SH, Peng C, Leon MP, et al. Expression and purification of secreted forms of HSV glycoproteins from baculovirus‐infected insect cells. Methods Mol Med. 1998; 10: 131 ‐ 156.
dc.identifier.citedreferenceMorrissey JH, Fair DS, Edgington TS. Monoclonal antibody analysis of purified and cell‐associated tissue factor. Thromb Res. 1988; 52: 247 ‐ 261.
dc.identifier.citedreferenceWaters EK, Morrissey JH. Restoring full biological activity to the isolated ectodomain of an integral membrane protein. Biochemistry. 2006; 45: 3769 ‐ 3774.
dc.identifier.citedreferenceHiggins DL, Mann KG. The interaction of bovine factor V and factor V‐derived peptides with phospholipid vesicles. J Biol Chem. 1983; 258: 6503 ‐ 6508.
dc.identifier.citedreferenceWienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein‐binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010; 1: 100.
dc.identifier.citedreferenceScheuermann TH, Padrick SB, Gardner KH, Brautigam CA. On the acquisition and analysis of microscale thermophoresis data. Anal Biochem. 2016; 496: 79 ‐ 93.
dc.identifier.citedreferenceNeuenschwander PF, Morrissey JH. Roles of the membrane‐interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem. 1994; 269: 8007 ‐ 8013.
dc.identifier.citedreferenceSen P, Neuenschwander PF, Pendurthi UR, Rao LVM. Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance. Blood Coagul Fibrinolysis. 2010; 21: 376 ‐ 379.
dc.identifier.citedreferenceRuf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid‐independent and ‐dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem. 1991; 266: 2158 ‐ 2166.
dc.identifier.citedreferenceHuang Q, Neuenschwander PF, Rezaie AR, Morrissey JH. Substrate recognition by tissue factor‐factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4‐carboxyglutamate‐rich domain of factor X. J Biol Chem. 1996; 271: 21752 ‐ 21757.
dc.identifier.citedreferencePetersen LC, Albrektsen T, Hjorto GM, Kjalke M, Bjorn SE, Sorensen BB. Factor VIIa/tissue factor‐dependent gene regulation and pro‐coagulant activity: effect of factor VIIa concentration. Thromb Haemost. 2007; 98: 909 ‐ 911.
dc.identifier.citedreferenceWaxman E, Ross JB, Laue TM, et al. Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry. 1992; 31: 3998 ‐ 4003.
dc.identifier.citedreferenceSmåbrekke B, Rinde LB, Hindberg K, et al. Atherosclerotic risk factors and risk of myocardial infarction and venous thromboembolism; time‐fixed versus time‐varying analyses. The Tromsø Study. PLoS One. 2016; 11: e0163242.
dc.identifier.citedreferenceAnderson FAJ, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003; 107: I9 ‐ 16.
dc.identifier.citedreferenceGregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019; 4: 163 ‐ 173.
dc.identifier.citedreferencePrevitali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011; 53: 120 ‐ 138.
dc.identifier.citedreferenceYonemitsu Y. Viruses and vascular disease. Nat Med. 1998; 4: 253.
dc.identifier.citedreferenceMorre S, Stooker W, Lagrand W, van den Brule AJC, Niessen H. Microorganisms in the aetiology of atherosclerosis. J Clin Pathol. 2000; 53: 647 ‐ 654.
dc.identifier.citedreferenceFunahara Y, Sumarmo WR. Features of DIC in dengue hemorrhagic fever. Bibl Haematol. 1983; 201 ‐ 211.
dc.identifier.citedreferenceSrichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol. 2000; 13: 261 ‐ 276.
dc.identifier.citedreferenceChuansumrit A, Chaiyaratana W. Hemostatic derangement in dengue hemorrhagic fever. Thromb Res. 2014; 133: 10 ‐ 16.
dc.identifier.citedreferenceAmbrosino P, Tarantino L, Criscuolo L, Nasto A, Celentano A, Di Minno MN. The risk of venous thromboembolism in patients with hepatitis C. A systematic review and meta‐analysis. Thromb Haemost. 2016; 116: 958 ‐ 966.
dc.identifier.citedreferenceKiefer EM, Shi Q, Hoover DR, et al. Association of hepatitis C with markers of hemostasis in HIV‐infected and uninfected women in the women’s interagency HIV study (WIHS). J Acquir Immune Defic Syndr. 2013; 62: 301 ‐ 310.
dc.identifier.citedreferenceVioli F, Ferro D, Basili S, et al. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Investig Med. 1995; 43: 550 ‐ 554.
dc.identifier.citedreferenceBibas M, Biava G, Antinori A. HIV‐associated venous thromboembolism. Mediterr J Hematol Infect Dis. 2011; 3: e2011030.
dc.identifier.citedreferenceGarlassi E, Carli F, Orlando G, et al. Premature age‐related comorbidities among HIV‐infected persons compared with the general population. Clin Infect Dis. 2011; 53: 1120 ‐ 1126.
dc.identifier.citedreferenceVercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis. 1998; 9 ( Suppl 2 ): S3 ‐ S6.
dc.identifier.citedreferenceEtingin OR, Hajjar DP. Evidence for cytokine regulation of cholesterol metabolism in herpesvirus‐infected arterial cells by the lipoxygenase pathway. J Lipid Res. 1990; 31: 299 ‐ 305.
dc.identifier.citedreferenceSpan AH, van Dam‐Mieras MC, Mullers W, Endert J, Muller AD, Bruggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest. 1991; 21: 331 ‐ 338.
dc.identifier.citedreferenceKey NS, Vercellotti GM, Winkelmann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A. 1990; 87: 7095 ‐ 7099.
dc.identifier.citedreferenceHarrington KJ, Andtbacka RH, Collichio F, et al. Efficacy and safety of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Onco Targets Ther. 2016; 9: 7081 ‐ 7093.
dc.identifier.citedreferenceLeite J, Ribeiro A, Goncalves D, Sargento‐Freitas J, Trindade L, Duque V. Cerebral venous thrombosis as rare presentation of herpes simplex virus encephalitis. Case Rep Infect Dis. 2019; 2019: 7835420.
dc.identifier.citedreferenceGörek A, Akçay Ş, Ibiş OA, et al. Herpes simplex virus infection, massive pulmonary thromboembolism, and right atrial thrombi in a single patient: case report. Heart Lung. 2007; 36: 148 ‐ 153.
dc.identifier.citedreferenceLi JZ, Sax PE. HSV‐1 encephalitis complicated by cerebral hemorrhage in an HIV‐positive person. AIDS Read. 2009; 19: 153 ‐ 155.
dc.identifier.citedreferenceSingh TD, Fugate JE, Hocker S, Wijdicks EFM, Aksamit AJ, Rabinstein AA. Predictors of outcome in HSV encephalitis. J Neurol. 2016; 263: 277 ‐ 289.
dc.identifier.citedreferenceSutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial EL. Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A. 1997; 94: 13510 ‐ 13514.
dc.identifier.citedreferenceSutherland MR, Ruf W, Pryzdial ELG. Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease‐activated receptor 2 cofactors that enhance infection. Blood. 2012; 119: 3638 ‐ 3645.
dc.identifier.citedreferencePryzdial EL, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood. 1994; 84: 3749 ‐ 3757.
dc.identifier.citedreferenceAasrum M, Prydz H. Gene targeting of tissue factor, factor X, and factor VII in mice: their involvement in embryonic development. Biochemistry (Mosc). 2002; 67: 25 ‐ 32.
dc.identifier.citedreferenceNakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 1991; 30: 10819 ‐ 10824.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jth14790-sup-0001-Supinfo.pdf
Size:
486.9KB
Format:
PDF
View/Open
Name:
jth14790.pdf
Size:
1.233MB
Format:
PDF
View/Open
Name:
jth14790_am.pdf
Size:
471.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.